WAIKOLOA, Hawaii — In this expert perspective from Hawaiian Eye 2026, John D. Sheppard, MD, MMSc, FACS, discusses “exciting” treatments for neurotrophic keratitis.
Sheppard, of Virginia Eye Consultants, highlights therapies for neurotrophic keratitis as well as treatment modalities for severe cases, such as Oxervate (cenegermin-bkbj, Dompé), amniotic membranes and preventive measures in high-risk populations. Therapies in the pipeline include a hepatocyte growth factor from Claris Bio.
“There are several other companies looking at neurotrophic disease as well, which will come to the forefront